Merck’s HIV treatment meets main goal of two late-stage studies
By Thomson ReutersDec 19, 2024 | 5:59 AM
(Reuters) – Merck said on Thursday its experimental drug combination to treat some adults with HIV-1 infection met the main goal of two late-stage studies.
(Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar)
For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at 715-842-1672.